Lista de obras - Roumen Milev - Dominio Público Uruguay

A National Survey on Nursing in Canadian ECT Departments

artículo científico publicado en 2017

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.

artículo científico publicado en 2009

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder

artículo científico publicado en 2013

Access to electroconvulsive therapy services in Canada

artículo científico publicado en 2011

Add-on quetiapine for bipolar depression: a 12-month open-label trial

artículo científico publicado en 2006

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study

artículo científico publicado en 2010

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report

scientific article published on 13 January 2020

Anticipated discrimination among people with schizophrenia.

artículo científico publicado en 2011

Book Review: Global Mental Health: Essentials of Global Mental HealthEssentials of Global Mental Health Okpaku Samuel O, editor. Cambridge (GB): Cambridge University Press; 2014. 465 p. Can$135.00n

book review, 2015

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods

artículo científico publicado en 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care

artículo científico publicado en 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

artículo científico publicado en 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments

scientific article published on 02 August 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

artículo científico publicado en 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

artículo científico publicado en 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

artículo científico publicado en 2016

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies

artículo científico publicado en 2009

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

artículo científico publicado en 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

artículo científico publicado en 2009

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

artículo científico publicado en 2012

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

artículo científico publicado en 2009

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

artículo científico publicado en 2005

Canadian survey of perianesthetic care for patients receiving electroconvulsive therapy

artículo científico publicado en 2012

Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report

scientific article published on 04 October 2019

Clinical effectiveness: the importance of psychosocial functioning outcomes

artículo científico publicado en 2011

Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study

artículo científico publicado en 2006

Cognitive remediation for treatment-resistant depression: effects on cognition and functioning and the role of online homework

artículo científico publicado en 2013

Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pa

artículo científico publicado en 2017

Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial

artículo científico publicado en 2016

Comparison of stigmatizing experiences between Canadian and Korean patients with depression and bipolar disorders

artículo científico publicado en 2015

Corrigendum to “A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study” Schizophr. Res. 113 (2009) 41-48

scholarly article published in Schizophrenia Research

Delivery of electroconvulsive therapy in Canada: a first national survey report on devices and technique

artículo científico publicado en 2013

Delivery of electroconvulsive therapy in Canada: a first national survey report on usage, treatment practice, and facilities

artículo científico publicado en 2015

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.

artículo científico publicado en 2016

Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report

artículo científico publicado en 2018

Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression ⬇️

artículo científico publicado en 2012

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression ⬇️

artículo científico publicado el 7 de septiembre de 2010

Effects, experiences, and impact of stigma on patients with bipolar disorder

artículo científico publicado en 2013

Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials.

artículo científico publicado en 2017

Electroconvulsive therapy teaching in Canada: cause for concern

artículo científico publicado en 2013

Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review

artículo científico publicado en 2017

Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study

artículo científico publicado en 2019

Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder.

artículo científico publicado en 2010

Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment

artículo científico publicado en 2016

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient

artículo científico publicado en 2017

Functional competence in major depressive disorder: Objective performance and subjective perceptions.

artículo científico publicado en 2018

Geographic Accessibility of ECT Services in Canada

article

Harnessing the potential of community-based participatory research approaches in bipolar disorder

artículo científico publicado en 2016

Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report

scientific article published on 14 October 2019

Identification of primary polydipsia in a severe and persistent mental illness outpatient population: a prospective observational study

artículo científico publicado en 2013

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

artículo científico publicado en 2017

Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes

artículo científico publicado en 2019

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants

artículo científico publicado en 2019

International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)

scientific article published on 04 December 2019

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

artículo científico publicado en 2017

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study

artículo científico publicado en 2022

Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: A retrospective study

artículo científico publicado en 2008

Multisensory stimulation for elderly with dementia: a 24-week single-blind randomized controlled pilot study.

artículo científico publicado en 2008

Neurostimulation in Anxiety Disorders, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder

artículo científico publicado en 2020

Olfactory Functioning and Depression: A Systematic Review

artículo científico publicado en 2017

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.

artículo científico publicado en 2015

Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial Protocol

artículo científico publicado en 2017

Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment

scientific article published on 07 May 2019

Public knowledge, beliefs and attitudes towards patients with schizophrenia: Buenos Aires

artículo científico publicado en 2010

Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines

artículo científico publicado en 2017

Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study

scientific article published on 06 July 2019

Relationships among neurocognition, symptoms, and functioning in treatment-resistant depression

artículo científico publicado en 2013

Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants

scientific article published on 03 December 2019

Repetitive transcranial magnetic stimulation for treatment of medication-resistant depression in older adults: a case series

artículo científico publicado en 2009

Repetitive transcranial magnetic stimulation of the right dorsal lateral prefrontal cortex in the treatment of generalized anxiety disorder: A randomized, double-blind sham controlled clinical trial.

artículo científico publicado en 2017

Response of depression to botulinum toxin treatment: agitation as a predictor

artículo científico publicado en 2015

Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression

artículo científico publicado en 2017

Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines.

artículo científico publicado en 2013

Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers

scientific article published on 23 November 2019

Risk of schizophrenia increased with increasing paternal age

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial

artículo científico publicado en 2014

Sleep architecture in ziprasidone-treated bipolar depression: a pilot study

artículo científico publicado en 2013

Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study

scientific article published on 01 November 2019

Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression

artículo científico

Stigma and discrimination in people suffering with a mood disorder: a cross-sectional study

artículo científico publicado en 2012

Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature

artículo científico publicado en 2003

T3 augmentation of SSRI resistant depression

artículo científico publicado en 2006

Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants

scientific article published on 07 May 2019

The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction

artículo científico publicado en 2012

The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

scientific article published on 01 July 2019

The Canadian Survey of Standards of Electroconvulsive Therapy Practice: a call for accreditation

artículo científico publicado en 2012

The Default Mode Network in Healthy Individuals: A Systematic Review and Meta-Analysis.

artículo científico publicado en 2016

The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Placebo-Controlled Trial

scientific article published on 13 February 2019

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study

artículo científico publicado en 2021

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

artículo científico publicado en 2020

The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.

artículo científico publicado en 2017

The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.

artículo científico publicado en 2022

The effects of probiotics on depressive symptoms in humans: a systematic review

artículo científico publicado en 2017

The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future.

artículo científico publicado en 2013

The experience and impact of stigma in Saudi people with a mood disorder

artículo científico publicado en 2018

The manic phase of Bipolar disorder significantly impairs theory of mind decoding

artículo científico publicado en 2016

The neurobiology of the EEG biomarker as a predictor of treatment response in depression

artículo científico

The role of electroconvulsive therapy in the treatment of bipolar disorder

Towards a Better Future for Canadians with Bipolar Disorder: Principles and Implementation of a Community-Based Participatory Research Model

Transcranial Magnetic Stimulation of the Supplementary Motor Area in the Treatment of Obsessive-Compulsive Disorder: A Multi-Site Study

artículo científico publicado en 2016

Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression

artículo científico publicado en 2020

Utility of the Berlin questionnaire for predicting obstructive sleep apnea in individuals with treatment-resistant depression

artículo científico publicado en 2013

White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study

scientific article published on 12 June 2019

Lista de obras de Roumen Milev

A National Survey on Nursing in Canadian ECT Departments

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder

Access to electroconvulsive therapy services in Canada

Add-on quetiapine for bipolar depression: a 12-month open-label trial

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report

Anticipated discrimination among people with schizophrenia.

Book Review: Global Mental Health: Essentials of Global Mental HealthEssentials of Global Mental Health Okpaku Samuel O, editor. Cambridge (GB): Cambridge University Press; 2014. 465 p. Can$135.00n

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

Canadian survey of perianesthetic care for patients receiving electroconvulsive therapy

Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report

Clinical effectiveness: the importance of psychosocial functioning outcomes

Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study

Cognitive remediation for treatment-resistant depression: effects on cognition and functioning and the role of online homework

Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pa

Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial

Comparison of stigmatizing experiences between Canadian and Korean patients with depression and bipolar disorders

Corrigendum to “A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study” Schizophr. Res. 113 (2009) 41-48

Delivery of electroconvulsive therapy in Canada: a first national survey report on devices and technique

Delivery of electroconvulsive therapy in Canada: a first national survey report on usage, treatment practice, and facilities

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.

Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report

Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression ⬇️

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression ⬇️

Effects, experiences, and impact of stigma on patients with bipolar disorder

Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials.

Electroconvulsive therapy teaching in Canada: cause for concern

Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review

Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study

Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder.

Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient

Functional competence in major depressive disorder: Objective performance and subjective perceptions.

Geographic Accessibility of ECT Services in Canada

Harnessing the potential of community-based participatory research approaches in bipolar disorder

Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report

Identification of primary polydipsia in a severe and persistent mental illness outpatient population: a prospective observational study

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants

International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study

Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: A retrospective study

Multisensory stimulation for elderly with dementia: a 24-week single-blind randomized controlled pilot study.

Neurostimulation in Anxiety Disorders, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder

Olfactory Functioning and Depression: A Systematic Review

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.

Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial Protocol

Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment

Public knowledge, beliefs and attitudes towards patients with schizophrenia: Buenos Aires

Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines

Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study

Relationships among neurocognition, symptoms, and functioning in treatment-resistant depression

Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants

Repetitive transcranial magnetic stimulation for treatment of medication-resistant depression in older adults: a case series

Repetitive transcranial magnetic stimulation of the right dorsal lateral prefrontal cortex in the treatment of generalized anxiety disorder: A randomized, double-blind sham controlled clinical trial.

Response of depression to botulinum toxin treatment: agitation as a predictor

Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression

Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines.

Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers

Risk of schizophrenia increased with increasing paternal age

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial

Sleep architecture in ziprasidone-treated bipolar depression: a pilot study

Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study

Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression